Wed Feb 03 2021

Policlínica Nuestra Señora del Rosario, a private hospital in Ibiza, recently joined our expanding customer base in Spain. This hospital, equipped with 70 beds, offers acute care and outpatient treatments to both locals and tourists, serving an approximate population of 50,000. Alongside the main hospital, three smaller clinics are associated with it.

The hospital has decided to implement our suPARnostic® TurbiLatex product on its Roche cobas 501 system immediately. This decision came after considering positive feedback from other hospitals in Spain and internationally, despite lacking firsthand experience with our product.

We aim to enhance the hospital’s ability to triage COVID-19 patients and other acute care patients more effectively with the introduction of our product.

Jakob Knudsen, Chief Executive Officer of ViroGates, said:

”We are happy to add another clinical customer to our list of already established customers in Spain. We are particularly encouraged to see that this customer has decided to implement suPARnostic® based on data from peers in Spain and abroad without previous on-site experience. This shows that clinical evidence, local reference hospitals and our targeted marketing work in combination to convince customers who have not been acquainted with our products previously.”

1000+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates